Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 75.48

+1.4%

Nov 14 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (1452)	12/9/2005 12:17:38 AM
From: Jibacoa	Read Replies (2) of 3722

Following on some comments that I was making on another thread and that I decided to cut short since I think it was getting somewhat O.T. for that thread.<g> Message 21957289 VPHM Was on the list on which some comments were mad there in July 2004.<g> Message 20335913 And it did perform well this year.<g> bigcharts.marketwatch.com CVTX In spite of its poor revenues and persistent large red ink, has managed to hold above the trendlines this year with the help of some good announcements at its large institutional investors.<g> biz.yahoo.com finance.yahoo.com bigcharts.marketwatch.com INCY Which was also on that list, hasn't been able to get off from its downtrend, albeit it is now trying to close its September 29 downgap and it had an upgap on November 21 after it announced its cooperation with PFE.<g> bigcharts.marketwatch.com bigcharts.marketwatch.com DRRX Which was also on that list in July 2004 did double this year from May to late August after the price was able to get above the trendlines and with the help of insider buying and the announcement of its deal with ENDP which licensed DRRX analgesic patch.<g> bigcharts.marketwatch.com PRCS Which was the last one on that list in July, seems ready to get off its longterm downtrend.<g> It had 95% better revenues on its 3rdQ and although the loss for this year is still expected to reach $6.00/shr in spite of the significant improvement on its loss for the 3rdQ, for 2006 the estimate L is expected to be cut down to $1.30/shr (That would be the best result since 1999 whe if closed with $1.20/shr on the black column.<g>) bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next